1-3 of 3 results for subject:"Our Future Health"
Librarians' tools
- Search time
- 0.176 seconds
- Solr query time
- 0.001 seconds
- Search query
- subject:"Our Future Health"
- We searched for
- subject_t:"Our Future Health" OR subject_ses:515648
Type
House
Session
Year
Department
Member
Primary member
Answering member
Legislative stage
Legislation
Subject
Publisher
To ask the Secretary of State for Science, Innovation and Technology, what is the estimated total cost to the public purse of the Our Future Health research programme.
To ask the Secretary of State for Science, Innovation and Technology, what is the estimated total cost to the public purse of the Our Future Health research programme.
As announced in the Life Sciences Sector Plan, the government allocated £354m CDEL R&D Spending Review phase 2 funding from 2026/27 to 2029/30 to Our Future Health to become the largest longitudinal health research cohort and clinical trials resource in the world, with up to 5 million consented participants by 2030. This follows earlier investment of £58m CDEL R&D in 2026/27 from Spending Review phase 1, £79m CDEL R&D from the Industrial Strategy Challenge Fund, which established the programme, and £81m CDEL R&D from repurposed underspend to fund additional objectives.
To ask the Secretary of State for Science, Innovation and Technology, with reference to the UK’s Modern Industrial Strategy, CP 1337, published on 23 June 2025, what proportion of funding for Our Future Health will be allocated to (a) developing non-animal methods of testing and (b) phasing out animal testing.
To ask the Secretary of State for Science, Innovation and Technology, with reference to the UK’s Modern Industrial Strategy, CP 1337, published on 23 June 2025, what proportion of funding for Our Future Health will be allocated to (a) developing non-animal methods of testing and (b) phasing out animal testing.
Genomics England, Our Future Health and UK Biobank contribute important human data to the UK’s diverse research portfolio that supports alternative method development, including organ-on-a-chip, cell-based assays, functional genomics and computer modelling. The Health Data Research Service will also contribute in future, However, this research is not categorised by application, so calculating funding for alternative methods specifically is not possible. UKRI also invests £10 million annually in the National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs), with future investment under review.
The Government will publish a strategy to support alternative methods later this year.
To ask the Secretary of State for Science, Innovation and Technology, if she will make an assessment of the potential merits of including kidney function testing in the Our Future Health research programme.
To ask the Secretary of State for Science, Innovation and Technology, if she will make an assessment of the potential merits of including kidney function testing in the Our Future Health research programme.
Our Future Health continues to work in partnership with charities including Kidney Research UK to develop additional sampling strategies that may in future include an assessment of kidney function.